Literature DB >> 19703431

Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.

Selene Lomoio1, Elda Scherini, Daniela Necchi.   

Abstract

It is known that in the nervous tissue beta-amyloid overproduction and its extracellular or intracellular deposition can activate mitogen-activated protein kinases involved in tau protein phosphorylation. Hyperphosphorylated tau is not more able to bind neuron microtubules, leading to their disassembly and axon degeneration. We have previously described that at 10 months of age in the cerebellum of Ts65Dn mice, which are partially trisomic for the chromosome 16 and are considered a valuable model for Down syndrome, Purkinje cells undergo axon degeneration. Taking into consideration that Ts65Dn mice carry three copies of the gene encoding for the amyloid precursor protein, to characterize potential signaling events triggering the degenerative phenomenon, specific antibodies were used to examine the role of beta-amyloid overload in the activation of the stress activated kinase/c-jun N-terminal kinase (SAPK/JNK) and tau protein phosphorylation in the cerebellar cortex of 12-month-old Ts65Dn mice. We found small extracellular deposits of beta-amyloid at the borderline between the granule cell layer and the white matter, i.e., in the vicinity of the area where calbindin immunostaining of Purkinje cell axons revealed clusters of newly formed terminals of injured axons. Moreover, intracellular deposits were present in the somata of Purkinje cells. The level of activation of SAPK/JNK was greatly increased. The activation occurred in the "pinceaux" made by basket interneuron axons at the axon hillock of Purkinje cells. Antibody directed against tau protein phosphorylated at Ser-396/Ser-404 revealed positive NG2 cells and Bergman fibers in the molecular layer and oligodendrocytes in the white matter. Data indicate that beta-amyloid extracellular deposits could have exerted a local cytotoxic effect, leading to Purkinje cell axon degeneration. The activation of SAPK/JNK in basket cell "pinceaux" may be a consequence of altered functionality of Purkinje cells and may represent an attempt of basket cells of synaptic remodeling. Moreover, the findings for tau protein phosphorylation suggest that Ts65Dn mice are affected by a cerebellar glial tauopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703431     DOI: 10.1016/j.brainres.2009.08.052

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 2.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

3.  Age-related neurodegeneration and memory loss in down syndrome.

Authors:  Jason P Lockrow; Ashley M Fortress; Ann-Charlotte E Granholm
Journal:  Curr Gerontol Geriatr Res       Date:  2012-03-20

4.  Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome.

Authors:  Antonella Tramutola; Chiara Lanzillotta; Eugenio Barone; Andrea Arena; Ilaria Zuliani; Luciana Mosca; Carla Blarzino; D Allan Butterfield; Marzia Perluigi; Fabio Di Domenico
Journal:  Transl Neurodegener       Date:  2018-11-06       Impact factor: 8.014

5.  Cerebellar Calcium-Binding Protein and Neurotrophin Receptor Defects in Down Syndrome and Alzheimer's Disease.

Authors:  Jennifer C Miguel; Sylvia E Perez; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  Front Aging Neurosci       Date:  2021-03-12       Impact factor: 5.750

Review 6.  Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome.

Authors:  Helin Atas-Ozcan; Véronique Brault; Arnaud Duchon; Yann Herault
Journal:  Genes (Basel)       Date:  2021-11-20       Impact factor: 4.096

Review 7.  Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics.

Authors:  Nicole Créau
Journal:  Neural Plast       Date:  2012-07-12       Impact factor: 3.599

8.  Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder.

Authors:  Zhiyou Cai; Yong Yan; Yonglong Wang
Journal:  Clin Interv Aging       Date:  2013-08-19       Impact factor: 4.458

9.  Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model.

Authors:  Tomer Illouz; Ravit Madar; Arya Biragyn; Eitan Okun
Journal:  Brain Behav Immun       Date:  2018-10-25       Impact factor: 7.217

10.  Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.

Authors:  Aarti Ruparelia; Frances Wiseman; Olivia Sheppard; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  J Biomed Res       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.